• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Blood Adv . Inflammasome activation in neutrophils of patients with severe COVID-19

tetano

Editor, Senior Moderator
Blood Adv


. 2022 Jan 6;bloodadvances.2021005949.
doi: 10.1182/bloodadvances.2021005949. Online ahead of print.
Inflammasome activation in neutrophils of patients with severe COVID-19


Karen Aymonnier[SUP] 1 [/SUP], Julie Ng[SUP] 2 [/SUP], Laura E Fredenburgh[SUP] 2 [/SUP], Katherin Zambrano-Vera[SUP] 2 [/SUP], Patrick Münzer[SUP] 3 [/SUP], Sarah Gutch[SUP] 4 [/SUP], Shoichi Fukui[SUP] 3 [/SUP], Michael Desjardins[SUP] 2 [/SUP], Meera Subramaniam[SUP] 4 [/SUP], Rebecca Baron[SUP] 2 [/SUP], Benjamin A Raby[SUP] 4 [/SUP], Mark A Perrella[SUP] 2 [/SUP], James A Lederer[SUP] 5 [/SUP], Denisa D Wagner[SUP] 5 [/SUP]



Affiliations

Abstract

Infection by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) engages the inflammasome in monocytes and macrophages and leads to the cytokine storm in COVID-19. Neutrophils, the most abundant leukocytes, release neutrophil extracellular traps (NETs), which have been implicated in the pathogenesis of COVID-19. Our recent study shows that activation of the NLRP3 inflammasome is important for NET release in sterile inflammation. However, the role of neutrophil inflammasome formation in human disease is unknown. We hypothesized that SARS-COV-2 infection may induce inflammasome activation in neutrophils. We also aimed to assess the localization of inflammasome formation, (i.e. ASC speck assembly), and timing relative to NETosis in stimulated neutrophils by real time video microscopy. Neutrophils isolated from severe COVID-19 patients demonstrated that approximately 2% of neutrophils in both the peripheral blood and tracheal aspirates presented ASC speck. ASC speck was observed in neutrophils with an intact poly-lobulated nucleus, suggesting early formation during neutrophil activation. Additionally, 40% of nuclei were positive for citrullinated histone H3, and there was a significant correlation between speck formation and nuclear histone citrullination. Time-lapse microscopy in LPS-stimulated neutrophils from fluorescent ASC reporter mice showed that ASC speck formed transiently and at the microtubule organizing center, long before NET release. Our study shows that ASC speck is present in neutrophils from COVID-19 patients with respiratory failure and that it forms early in NETosis. Our findings suggest that inhibition of neutrophil inflammasomes may be beneficial in COVID-19.
 
Back
Top Bottom